Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Soujanya Teneligliptin Hydrobromide

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Teneligliptin Hydrobromide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 800Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin
    Glenmark to launch Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin

    18 Oct 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/glenmark-to-launch-a-triple-drug-fdc-of-teneligliptin-dapagliflozin-metformin-in-india-for-type-2-diabetes-14798

    INDIAN PHARMA POST
    18 Oct 2023
    Share Share
    Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notified
    Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notified

    13 Nov 2022

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/anti-diabetes-drugs-and-patented-antivirals-to-get-cheaper-nlem-notified/95483953

    HEALTH ET
    13 Nov 2022
    Share Share
    Glenmark Pharma launches drug for diabetic patients with comorbidities
    Glenmark Pharma launches drug for diabetic patients with comorbidities

    20 Oct 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-launches-drug-for-diabetic-patients-with-comorbidities/articleshow/94981411.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    20 Oct 2022
    Share Share
    Pharma Readies For Price Caps On Glargine, Teneligliptin, Lenalidomide In India
    Pharma Readies For Price Caps On Glargine, Teneligliptin, Lenalidomide In India

    20 Sep 2022

    // Anju Ghangurde PINK SHEET

    https://pink.pharmaintelligence.informa.com/PS147023/Pharma-Readies-For-Price-Caps-On-Glargine-Teneligliptin-Lenalidomide-In-India

    Anju Ghangurde PINK SHEET
    20 Sep 2022
    Share Share
    Diabetes, patented TB, HIV drugs enter essential list
    Diabetes, patented TB, HIV drugs enter essential list

    13 Sep 2022

    // Teena Thacker ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-patented-tb-hiv-drugs-enter-essential-list/articleshow/94185393.cms

    Teena Thacker ECONOMICTIMES
    13 Sep 2022
    Share Share
    Glenmark launches fixed-dose combination medication for diabetic patients
    Glenmark launches fixed-dose combination medication for diabetic patients

    27 Apr 2022

    // ECONOMICTIMES

    https://health.economictimes.indiatimes.com/news/pharma/glenmark-becomes-the-first-pharmaceutical-company-to-launch-teneligliptin-pioglitazone-fixed-dose-combination-drug-for-type-2-diabetes-in-india/91112044

    ECONOMICTIMES
    27 Apr 2022
    Share Share